PERSPECTIVE THERAPEUTICS, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
PERSPECTIVE THERAPEUTICS, INC. (CATX) had Lessee, Operating Lease, Liability, to be Paid, Year One of $1.25 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-10
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $1.25M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.25M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $725.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $647.00K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $1.25M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $1.25M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $725.00K 10-K · filed 2026-03-16 |
| 2025-09-30 | $647.00K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $647.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $647.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $1.11M 10-K/A · filed 2025-03-28 |
| 2024-09-30 | $1.11M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $949.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $329.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $111.00K 10-K · filed 2024-03-28 |
| 2023-09-30 | $430.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $319.00K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $118.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $292.00K 10-KT · filed 2023-05-01 |
| 2022-09-30 | $264.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $292.00K 10-K · filed 2022-09-28 |
| 2022-03-31 | $292.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $292.00K 10-Q · filed 2022-02-09 |
| 2021-09-30 | $292.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $292.00K 10-K · filed 2021-09-27 |
| 2021-03-31 | $292.00K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $292.00K 10-Q · filed 2021-02-09 |
| 2020-09-30 | $292.00K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $290.00K 10-K · filed 2020-09-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |